Survey of stress ulcer prophylaxis
Background:
No surveys of stress ulcer prophylaxis prescribing in the USA have
been conducted since 1995. Since that time, the most comprehensive meta-analysis
and largest randomized study to date concerning stress ulcer prophylaxis have
been published.
Results:
Three hundred sixty-eight surveys were sent to all members of the
Section of Pharmacy and Pharmacology of the Society of Critical Care Medicine.
One hundred fifty-three (42%) surveys were returned. Representatives from 86%
of institutions stated that medications for stress ulcer prophylaxis are used
in a majority (>90%) of patients admitted to the intensive care unit (ICU).
Twenty-two per cent of institutions have recommendations for both ICU and
non-ICU settings. Fifty-eight per cent of institutions stated that there was
one preferred medication for stress ulcer prophylaxis, and in 77% of these
histamine-2-antagonists were the most popular.
Conclusions:
There are wide variations in prescribing practices for stress
ulcer prophylaxis. Institutions should consult published literature and use
pre-existing guidelines as templates for developing their own guidelines.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| bureauCode |
[
"009:25"
]
|
| contactPoint |
{
"fn": "NIH",
"@type": "vcard:Contact",
"hasEmail": "mailto:info@nih.gov"
}
|
| description | Background: No surveys of stress ulcer prophylaxis prescribing in the USA have been conducted since 1995. Since that time, the most comprehensive meta-analysis and largest randomized study to date concerning stress ulcer prophylaxis have been published. Results: Three hundred sixty-eight surveys were sent to all members of the Section of Pharmacy and Pharmacology of the Society of Critical Care Medicine. One hundred fifty-three (42%) surveys were returned. Representatives from 86% of institutions stated that medications for stress ulcer prophylaxis are used in a majority (>90%) of patients admitted to the intensive care unit (ICU). Twenty-two per cent of institutions have recommendations for both ICU and non-ICU settings. Fifty-eight per cent of institutions stated that there was one preferred medication for stress ulcer prophylaxis, and in 77% of these histamine-2-antagonists were the most popular. Conclusions: There are wide variations in prescribing practices for stress ulcer prophylaxis. Institutions should consult published literature and use pre-existing guidelines as templates for developing their own guidelines. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Official Government Data Source",
"mediaType": "text/html",
"description": "Visit the original government dataset for complete information, documentation, and data access.",
"downloadURL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC29030/"
}
]
|
| identifier | https://healthdata.gov/api/views/gjsd-y8pa |
| issued | 2025-07-13 |
| keyword |
[
"histamine-2-antagonists",
"icu-medication-use",
"nih",
"pharmacy-survey",
"stress-ulcer-prophylaxis"
]
|
| landingPage | https://healthdata.gov/d/gjsd-y8pa |
| modified | 2025-09-06 |
| programCode |
[
"009:032"
]
|
| publisher |
{
"name": "National Institutes of Health",
"@type": "org:Organization"
}
|
| theme |
[
"NIH"
]
|
| title | Survey of stress ulcer prophylaxis |
